Close Menu

NEW YORK — German diagnostics firm Epigenomics said on Thursday that it has issued a mandatory convertible bond with a nominal value of up to €5.5 million ($6.7 million).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.